drugset / Trial / NCT00400218
Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Evaluate the safety and anti-hypertensive efficacy of hyzaar(R) in patients with mild to moderate essential hypertension.
Timeline
- Start
- 2005-09-01
- Primary completion
- 2006-07-01
- Completion
- 2006-07-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrochlorothiazide | Unknown | 12.5 mg | — |
| Subject | Losartan | Other / unclassified | 50 mg | — |